Hot Stocks: Brokerages view on Aurobindo Pharma, Apollo Hospitals, Suzlon & Titan Company

June 3, 2024

Top brokerage firms like Macquarie maintained an outperform rating on Aurobindo Pharma, raising the target price to Rs 1,385. Aurobindo Pharma signed a master service agreement with Merck Sharp & Dohme, leading to a biologics CMO contract with TheraNym.

More To Explore

Who should invest in REITs? Understanding risk and investment goals

REITs have made premium real estate investment accessible to retail investors in India. They offer regular income, portfolio diversification, and liquidity while carrying market and

March 31, 2025

60 equity mutual funds lose up to 17% in FY25. Have you added any to your portfolio?

Around 60 mutual funds posted negative returns in FY25 out of 486 total funds. Samco Flexi Cap Fund was the worst performer, losing 17.24%. major

March 31, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003